AI cancer cures slowed by chip shortage, says Arm boss (www.bbc.com)

Rene Haas, CEO of Arm Holdings, announced that while artificial intelligence has the potential to discover cancer cures beyond human capability, the current progress is hampered by a global chip shortage necessary for advancing AI technologies. He believes that as computational models improve, AI will successfully tackle the complexities of cancer biology, a feat that exceeds human analytical capacities today. This ambition positions AI as a transformative force in medicine, especially as companies use unique patient-generated data to train AI, shifting the focus from sheer computational power to quality data. Haas also highlighted the robust demand for Arm’s chips, particularly in AI data centers, which are crucial for developing humanoid robots and other advanced applications. Despite the challenges posed by chip shortages and supply chain constraints, he emphasized that the evolution of AI technologies would not lead to mass unemployment but create new job opportunities. The discussion underscored the significance of Arm's contribution to AI infrastructure and its strategic role in the ongoing digital transformation across various sectors.